TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
LNTH

Lantheus Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

99.70$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Lantheus Holdings Inc (LNTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,415 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LNTH
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,522 1,651 1,831 1,940 2,050 1,980 2,055 2,116 2,276 2,227 2,347 2,415
948 1,086 1,149 1,231 1,296 1,327 1,424 1,202 925 900 942 1,027
614 714 718 757 866 913 939 696 382 359 499 593
614 714 718 757 866 913 939 696 382 359 499 593
259 284 337 372 329 321 349 337 383 359 356 353
56 64 70 71 71 68 69 62 62 65 61 58
61 61 61 61 61 61 61 177 240 240 239 239
163 152 142 172 174 162 154 360 739 723 706 689
823 835 886 913 870 892 891 949 1,157 1,138 1,134 1,103
177 187 237 263 784 241 248 280 347 333 333 336
0.7 0.8 0.7 0.9 565 1.0 0.7 0.8 0.9 4.5 0.8 0.7
37 41 38 50 45 35 45 41 66 43 46 48
561 562 562 563 0.6 565 566 567 568 569 570 570
699 816 946 1,027 1,180 1,088 1,164 1,167 1,119 1,090 1,212 1,312
30 134 265 327 458 446 519 598 625 680 798 873
70 70 70 71 73 69 71 70 68 66 66 68

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?